JP2007518815A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518815A5
JP2007518815A5 JP2006551327A JP2006551327A JP2007518815A5 JP 2007518815 A5 JP2007518815 A5 JP 2007518815A5 JP 2006551327 A JP2006551327 A JP 2006551327A JP 2006551327 A JP2006551327 A JP 2006551327A JP 2007518815 A5 JP2007518815 A5 JP 2007518815A5
Authority
JP
Japan
Prior art keywords
composition
tenofovir
treating
dehobiru
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006551327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002043 external-priority patent/WO2005072748A1/en
Publication of JP2007518815A publication Critical patent/JP2007518815A/ja
Publication of JP2007518815A5 publication Critical patent/JP2007518815A5/ja
Pending legal-status Critical Current

Links

JP2006551327A 2004-01-21 2005-01-21 乳癌および原発性胆汁性肝硬変に関与するmmtv様ウイルスを阻害するためのアデホビルまたはテノホビルの使用 Pending JP2007518815A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53806604P 2004-01-21 2004-01-21
PCT/US2005/002043 WO2005072748A1 (en) 2004-01-21 2005-01-21 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Publications (2)

Publication Number Publication Date
JP2007518815A JP2007518815A (ja) 2007-07-12
JP2007518815A5 true JP2007518815A5 (cg-RX-API-DMAC7.html) 2008-03-13

Family

ID=34825960

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551327A Pending JP2007518815A (ja) 2004-01-21 2005-01-21 乳癌および原発性胆汁性肝硬変に関与するmmtv様ウイルスを阻害するためのアデホビルまたはテノホビルの使用

Country Status (10)

Country Link
US (2) US20070281911A1 (cg-RX-API-DMAC7.html)
EP (1) EP1732569B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007518815A (cg-RX-API-DMAC7.html)
AT (1) ATE445404T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005209256B2 (cg-RX-API-DMAC7.html)
CA (1) CA2553455A1 (cg-RX-API-DMAC7.html)
DE (1) DE602005017131D1 (cg-RX-API-DMAC7.html)
ES (1) ES2334149T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ548532A (cg-RX-API-DMAC7.html)
WO (1) WO2005072748A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1879657A2 (en) * 2005-04-25 2008-01-23 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
RU2301088C2 (ru) * 2005-09-01 2007-06-20 Ростовский научно-исследовательский онкологический институт МЗ РФ Способ лечения рецидива рака молочной железы
ATE534377T1 (de) 2006-05-16 2011-12-15 Gilead Sciences Inc Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen
ES2566762T3 (es) * 2009-10-05 2016-04-15 Ambergen Inc. Un procedimiento de diagnóstico de cirrosis biliar primaria (PBC) usando nuevos autoantígenos
WO2012048113A2 (en) 2010-10-07 2012-04-12 The General Hospital Corporation Biomarkers of cancer
US9089574B2 (en) 2011-11-30 2015-07-28 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
EP3161159B1 (en) 2014-06-25 2020-08-05 The General Hospital Corporation Targeting human satellite ii (hsatii)
WO2016106050A1 (en) 2014-12-26 2016-06-30 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
RU2020116571A (ru) 2017-12-07 2021-11-22 Эмори Юниверсити N4-гидроксицитидин и производные и связанные с этим противовирусные применения
KR102196711B1 (ko) * 2018-08-30 2020-12-30 가톨릭대학교 산학협력단 테노포비르 디소프록실 푸마르산을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물
WO2020171225A1 (ja) * 2019-02-22 2020-08-27 一素 村田 mTOR阻害剤
US12029783B2 (en) 2019-07-02 2024-07-09 Virago Vax Inc. Mammary tumor virus vaccine
US12016844B2 (en) 2019-07-02 2024-06-25 Virago Vax Inc. Mammary tumor virus suppression
EP3993873A4 (en) * 2019-07-02 2023-09-20 Virago Vax Inc. SUPPRESSION OF BREAST TUMORS
CN119546620A (zh) 2022-03-15 2025-02-28 罗梅治疗股份有限公司 用于治疗疾病的化合物和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073507A2 (en) * 1999-06-01 2000-12-07 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
ATE399204T1 (de) * 1999-06-30 2008-07-15 Univ Tulane Humanes endogenes retrovirus
HRP20030047B1 (hr) * 2000-07-21 2016-02-26 Gilead Sciences, Inc. Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava
IL164809A0 (en) * 2002-05-13 2005-12-18 Metabasis Therapeutics Inc Novel phosphonic acid basdrugs of pmea and its analogues

Similar Documents

Publication Publication Date Title
JP5763834B2 (ja) 置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン塩類
ES2609767T3 (es) Combinaciones de un inhibidor de PI3K y un inhibidor de MEK
CY1119865T1 (el) Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον
JP2008530108A5 (cg-RX-API-DMAC7.html)
ES2561495T3 (es) Régimen de tratamiento que utiliza neratinib contra cáncer de mama
JP2013543883A5 (cg-RX-API-DMAC7.html)
EP2751112A2 (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
JP2013516442A5 (cg-RX-API-DMAC7.html)
JP2016006096A5 (cg-RX-API-DMAC7.html)
JP2011529919A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2015536986A5 (cg-RX-API-DMAC7.html)
JP2013224953A5 (cg-RX-API-DMAC7.html)
JP2020523354A5 (cg-RX-API-DMAC7.html)
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
JP2016514727A5 (cg-RX-API-DMAC7.html)
JP2019501185A (ja) 食道癌を治療するためのキノリン誘導体の使用とその治療方法、医薬組成物及びキット
JP2015117185A5 (cg-RX-API-DMAC7.html)
JP2013511526A5 (cg-RX-API-DMAC7.html)
JP2023503167A5 (cg-RX-API-DMAC7.html)
AR040078A1 (es) Diaminotiazoles
JP2009515951A5 (cg-RX-API-DMAC7.html)
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
JP2008528617A5 (cg-RX-API-DMAC7.html)
IL201491A0 (en) Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands